Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for anemia in diabetic nephropathy
ChiCTR2200057232Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat in diabetic glomerulosclerosis, anaemia and type 2 diabetes mellitus (T2DM) (2 cohorts), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: Hemoglobin, Red blood cell count and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
diabetic glomerulosclerosisanaemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2200057232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057232.